Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.38 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.36 |
| ▸ | PIM1 | P11309 | 2/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 5/20 | 0.33 |
| ▸ | PPARA | Q07869 | 5/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13298546 | 1.00 | MCL1 (0.38) | MCL1ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL13298582 | 0.95 | PIM1 (0.36) | MCL1ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL13298587 | 0.95 | PIM1 (0.36) | MCL1ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL13298549 | 0.94 | HSD17B1 (0.35) | MCL1ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL13298555 | 0.94 | HSD17B1 (0.35) | MCL1ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL13298505 | 0.94 | PPARG (0.36) | MCL1ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL13298499 | 0.94 | PPARG (0.36) | MCL1ACMSDHDAC4HDAC2HDAC8 | |
| SCHEMBL13298542 | 0.91 | MCL1 (0.37) | MCL1ACMSDALDH1A1MAPTCA12 | |
| SCHEMBL13298545 | 0.91 | MCL1 (0.37) | MCL1ACMSDALDH1A1MAPTCA12 | |
| SCHEMBL13298550 | 0.91 | HSD17B1 (0.41) | ACMSDGPR84ADORA2AADORA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100133996-A1 | Novel anthracene typed compound and the organic electroluminescence display device using the same | DONGJIN SEMICHEM CO., LTD (KR) | 2010-06-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100133996-A1 | Novel anthracene typed compound and the organic electroluminescence display device using the same | TRPA1, TRPM2, TRPM4 | MCL1 3996/4885ACMSD 191/4885HDAC4 3769/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.